August 23, 2019 – health and escoliosis lumbar derecha wellness by marj shannon camp rehoboth

There’s good news on the pre- exposure prophylaxis (prep) front! Not that prep alone isn’t great news. After all, what’s not to love about a daily medicine (truvada®) that reduces the risk of getting HIV from sex by escoliosis lumbar derecha more than 90 percent? (among people who inject drugs, it reduces risk by more than 70 percent.) combined with condoms (“prep + 1”), your risk of getting HIV from sex can be lowered escoliosis lumbar derecha even further.

So—the current good news: soon, more people may be able to afford the drug—which is important, given it has an annual price tag (before discounts provided to insurers) of about $21,000. Although many insurers cover the drug, it may carry a high enough co-pay that potential users cannot access it.

What happened to improve that situation?

In june 2019, the US preventive services task force recommended that physicians offer escoliosis lumbar derecha prep to people at high risk of contracting human immunodeficiency escoliosis lumbar derecha virus (HIV). Recommendations made by the task force have implications for health escoliosis lumbar derecha insurers: as a result of this recommendation, starting in 2021, most health plans will be required to cover drugs recommended escoliosis lumbar derecha to prevent HIV, and patients cannot be charged anything out-of-pocket for the medication.

This could result in a real uptick in the number escoliosis lumbar derecha of people taking the drug. And that would be a very good thing: the centers for disease control and prevention (CDC) has estimated that 1.1 million people in the US could benefit from taking escoliosis lumbar derecha truvada. Gilead, the biotechnology company which developed and holds the patent on escoliosis lumbar derecha truvada, reported that during the second quarter of 2019 about 213,000 people were taking the drug for HIV prevention. That means that just under 20 percent of those people escoliosis lumbar derecha who could benefit are actually taking the drug. Clearly, there’s room for improvement.

Of course, some barriers to access remain: truvada is available only by prescription, and requires both pre-prescribing laboratory testing and quarterly laboratory monitoring. Typically, obtaining orders for that testing—as well as prescriptions for truvada—require physician (or clinic) office visits. The costs of both office visits and laboratory testing may—or may not—be covered by insurance.

In related news: gilead hopes soon to be marketing a newer drug, descovy, for HIV prevention. (the drug was approved in 2016 for treating people who escoliosis lumbar derecha already have HIV.) in early august, a US food and drug administration (FDA) advisory panel recommended the agency approve the drug for prevention escoliosis lumbar derecha purposes. Descovy has been shown in clinical trials to be less escoliosis lumbar derecha toxic to the bones and kidneys than truvada. At least for patients whose bones or kidneys are deemed escoliosis lumbar derecha to be at risk from truvada, descovy may provide an alternative.

Contact health & wellness director salvatore seeley (302-227-5620) to talk about what’s available and how to connect with resources. We offer HIV (and other STI) testing, and referrals to LGBTQ-friendly health care navigators who are familiar with prep. These individuals can prescribe prep and the periodic lab testing escoliosis lumbar derecha its use requires, and can even help you find resources to pay for escoliosis lumbar derecha the drug if your insurer does not cover it. More news on the prevention front

On june 26 of this year, a CDC advisory committee recommended that adults age 27 to escoliosis lumbar derecha 45 who have not been vaccinated against human papilloma virus escoliosis lumbar derecha (HPV) should receive the vaccine. Why is that important? Because infection from HPV, which is a group of more than 100 related viruses, is a major risk factor for six types of cancer.

Cancer of the cervix is the most common HPV-related cancer among women, accounting for just over half (53 percent) of the 20,300 HPV-related cancer cases reported among women as of august 2018. Vulvar and vaginal cancers accounted for 16 percent; anal cancer for 20 percent; and back-of-the-throat cancer for 11 percent.

Back-of-the-throat cancer is the most common HPV-related cancer among men, accounting for 80 percent of the 13,400 HPV-related cancer cases reported among men as of august 2018. Anal cancer accounted for 14 percent, and penile cancer for 6 percent.

They are prevented by that aforementioned vaccination. There is a two-dose series for children who are 11 or 12 years escoliosis lumbar derecha of age (or younger) when they receive the first dose; the second dose is given six to 12 months later. For people who start the series at age 15 or escoliosis lumbar derecha older, there is a three-dose series given over a period of six months.

Since their introduction, the vaccines have proven their effectiveness. For example, among teen girls, infections with HPV types that cause most HPV cancers have escoliosis lumbar derecha dropped 71 percent; among young adult women, these rates of infection have dropped 61 percent.

Fall into one of the groups recommended for vaccination? Talk to your health care provider! And if you don’t—maybe you have a child or grandchild or other family escoliosis lumbar derecha member or friend who does. Talk to them. Make sure they’re aware the vaccine is readily available—and can be a real life-saver. ▼ is prep right for you?

Has an HIV-positive partner; or has multiple partners, a partner with multiple partners, or a partner whose HIV status is unknown—and you also: don’t always use a condom for sex with people who escoliosis lumbar derecha inject drugs or don’t always use a condom for sex with bisexual men.